ArticleMedicine2026
Alcoholic cirrhosis with Wernicke encephalopathy: Clinical case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
rationaleEarly differentiation between hepatic encephalopathy and Wernicke encephalopathy (WE) is clinically critical in patients with decompensated alcoholic cirrhosis, as vitamin B1 deficiency can produce overlapping neurological symptoms that obscure the correct diagnosis and delay life-saving treatment. PATIENT CONCERNS: A 55-year-old male with a 2-year history of alcoholic cirrhosis was admitted to the hospital due to progressively worsening abdominal distension, diarrhea, and fatigue over the month prior to presentation. DIAGNOSES: WE was established based on the classic clinical triad of ocular motor dysfunction, ataxia, and mental confusion, supported by characteristic magnetic resonance imaging findings showing symmetric abnormal signals in the periaqueductal region of the midbrain.
interventionsInitial management comprised comprehensive ascites therapy addressing diarrhea, hyperlactatemia, hypokalemia, and hypoproteinemia. However, on the third hospital day, the patient acutely developed dysarthria, recent memory loss, hand tremors, unsteady gait, and strabismus, which prompted the immediate administration of high-dose intravenous vitamin B1, supplemented with intramuscular and oral B-complex vitamins. OUTCOMES: Following targeted thiamine repletion, the patient's neurological symptoms showed significant and rapid improvement. LESSONS: To our knowledge, this represents a rare case of WE in a critically ill alcoholic cirrhosis patient complicated by hepatic encephalopathy, in the absence of hepatocellular carcinoma or surgical intervention. This case strongly reinforces the need for clinicians to maintain a high index of suspicion for WE in such complex settings to enable timely diagnosis and intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.